Publications:

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients.

Clinical And Translational Medicine

Zheng, Qiufan Q; Hong, Shaodong S; Huang, Yan Y; Zhao, Hongyun H; Yang, Yunpeng Y; Hou, Xue X; Zhao, Yuanyuan Y; Ma, Yuxiang Y; Zhou, Ting T; Zhang, Yaxiong Y; Fang, Wenfeng W; Zhang, Li L

Publication Date: 2020-02-17

Variant appearance in text: TSC2: T70M

PubMed Link: 32067121

Variant Present in the following documents:

• Main text
• 40169_2020_Article_269.pdf

View BVdb publication page